HDAC6 and cystic fibrosis: Consistent with previous cell studies showing benefit of HDAC6 inhibition on CF cellular phenotypes, here it is shown that in vivo depletion of Hdac6 in a CF mouse model largely reverses CF responses to bacterial challenge to a more WT profile.